Asthma Trial, Recruiting (NCT04796844)

Asthma Trial, Recruiting NCT04796844 Sponsor: Societa Italiana di Pneumologia Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT04796844 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You must be an adult (18 years of age or older)
You must have been diagnosed with asthma, confirmed using standard medical guidelines (the GINA 2020 diagnostic process)
You must have already taken part in, or currently be taking part in, another observational research study

Who may not be able to join:

People whose asthma is classified as "severe asthma" according to international specialist guidelines (confirm with trial site)
People who have certain lung conditions such as scarring or inflammation of the lung tissue (interstitial lung diseases)
People who have a lung tumour or lung cancer (pulmonary neoplasms)
People who currently have an active lung infection
People who have an immune system disorder that requires them to take medication that suppresses the immune system
People who need to take steroid tablets (such as prednisolone) on an ongoing, continuous basis

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fulvio Braido, IRCCS Ospedale Policlinico San Martino, Department of Internal Medicine (DiMI), University of Genoa

Phone: + 393386036913

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04796844

Sponsor: Societa Italiana di Pneumologia

Phase: Not Applicable

Status: Recruiting

Condition: Asthma

Trial contact: + 393386036913

More information: https://clinicaltrials.gov/study/NCT04796844

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You must be an adult (18 years of age or older)
You must have been diagnosed with asthma, confirmed using standard medical guidelines (the GINA 2020 diagnostic process)
You must have already taken part in, or currently be taking part in, another observational research study

Who may not be able to join:

People whose asthma is classified as "severe asthma" according to international specialist guidelines (confirm with trial site)
People who have certain lung conditions such as scarring or inflammation of the lung tissue (interstitial lung diseases)
People who have a lung tumour or lung cancer (pulmonary neoplasms)
People who currently have an active lung infection
People who have an immune system disorder that requires them to take medication that suppresses the immune system
People who need to take steroid tablets (such as prednisolone) on an ongoing, continuous basis

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Societa Italiana di Pneumologia

Registry

ClinicalTrials.gov

Start date

1 May 2021

Est. completion

1 May 2021

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

A cluster-based, real world, cross-sectional perspective, observational cohort study

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov